Latest posts tagged with #Biogen on Bluesky
El nuevo régimen de dosificación está autorizado para uso tanto por pacientes AME nuevos con la terapia como aquellos que ya toman Spinraza.
🔗Lee el artículo completo en el siguiente link: lnkd.in/eC6rFQUG
#TheAkariFoundation #enfermedadesraras #AtrofiaMuscularEspinal #AME #Biogen #Spinraza
The headline says Biogen bought Apellis Pharmaceuticals for $5.6 billion.
The deeper story is that biotech may be starting to see kidney disease not as a difficult niche, but as a strategic market worth building around.
#Biotech #KidneyDisease #Nephrology #Biogen #TechNews
Biogen Flags $0.19 Hit to Q1 EPS: Biogen warned of a ~$0.19 hit to Q1 2026 EPS on Apr 6, 2026 (Seeking Alpha); investors should watch the company's 10-Q for whether the charge is non-recurring. 👈 Read full analysis #Biogen #EarningsReport #Q1Earnings #StockMarket #Investing
Biogen Files Form 8-K for April 6, 2026: Biogen filed a Form 8‑K on Apr 6, 2026 (10:41:15 GMT); the SEC requires 8‑Ks within 4 business days — review EDGAR exhibits to assess materiality. 👈 Read full analysis #Biogen #Form8K #SEC #Investing #FinanceNews
Biogen Signals $34 Million Deal-Related Charge as It Reshapes Earnings Strategy
#biogen #biotechnology #earnings #deal #pharma
Acquisitions: #FifthThirdBancorp > #Comerica
Agreed Acquisitions: #Biogen > #ApellisPharmaceuticals; #EliLilly > #CentessaPharmaceuticals; #Novartis > #Excellergy; #Sysco > #RestaurantDepot; #Uber > #Blacklane
SPAC: #IQMQuantumComputers
Closure: #Yupp
Apellis Downgraded by Roth, MKM after Biogen Deal: Roth and MKM downgraded Apellis on Apr 2, 2026; 2 analysts cut ratings after Biogen acquisition, raising near-term valuation and liquidity questions. 👈 Read full analysis #Apellis #Biogen #Roth #MKM #Downgrade
Investigation Launched into Apellis Pharmaceuticals Acquisition Deal by Monteverde & Associates #United_States #New_York #Monteverde_Associates #Biogen #Apellis_Pharmaceuticals
Article image
Biogen acquires Apellis for $5.6B to expand kidney drugs 💰💉. A major biotech move! Let's see how biotech and healthcare stocks react... #Biogen #Apellis #Pharma #Markets #Investing #BreakingBroke
Article image
Biogen acquista Apellis per 5,6 miliardi di dollari per espandere i farmaci renali 💰💉. Una grande mossa nel settore biotech! Vediamo come reagiranno i titoli biotech e sanitari... #Biogen #Apellis #Farmaceutica #Borsa #Investimenti #TachicardiaTrading
Ademi Firm Raises Concerns Over Apellis Pharmaceuticals' Fairness to Shareholders #USA #Milwaukee #Biogen #Ademi_Firm #Apellis_Pharmaceuticals
In today's second sizeable M&A deal, #Biogen has agreed to buy #Apellis for around $5.6 billion, seeking to get control of two approved therapies for #kidney and #eyedisorders.
buff.ly/Svvq4g9
Biogen Shares Rise After Positive Litifilimab Phase 2 CLE Data: Biogen reported a second positive Phase 2 litifilimab result at Week 16; data presented Mar 28, 2026 (source: Business Insider/GlobeNewswire). 👈 Read full analysis #Biogen #Litifilimab #Phase2ClinicalTrial #Pharmaceuticals #Healthcare
Alteogen and Biogen Partner for The Development of Subcutaneous Biologics with Hybrozyme™ Technology #South_Korea #Biogen #Daejeon #Alteogen #Hybrozyme
Unveiling Long-Term Benefits of LEQEMBI® in Alzheimer's Treatment: Real-World Insights #USA #Cambridge #Eisai #Biogen #LEQEMBI®
Biogen elevated Maria C. Freire to board chair.
Chair changes rarely move stocks — but in biotech, they shape risk posture, pipeline patience, and M&A appetite.
The signal shows up later in capital allocation.
What’s the first behavioral shift you’d look for?
#Biogen #InvestorLens
Three years after its first launch in the US, there are signs that #Biogen and #Eisai's #Alzheimer's #Leqembi therapy is gathering sales momentum.
pharmaphorum.com/news/leqembi...
Eisai and Biogen are developing a new version of their Alzheimer’s drug, LEQEMBI IQLIK, that patients could inject at home. The FDA has accepted it for Priority Review, with a decision expected in May 2026.
aktiego.com/new-leqembi-...
#Alzheimers #Healthcare #Biogen #Eisai #Pharma
Something big is coming.
22.01.2026
Stay tuned to our Informed Sport partner Biogen next Thursday for an exciting announcement!
#WeTestYouTrust #InformedSport #Biogen #ComingSoon
Proximity Health Solutions and Biogen Selected as Finalists for '26 SCOPE Engagement Award #USA #Stamford #Biogen #Better_Together #Lupus_Warrior
#neurology #NICE #Biogen #natalizumab #Tysabri #multiplesclerosis #MS #activerelapsingremittingmultiplesclerosis #biosimilar #NICEdraftguidance #Sandoz #PolpharmaBiologics #biosimilarequivalent #Tyruko #activerelapsingremittingMS #rapidlyevolvingsevereMS #biosimilarmedicines
zurl.co/tsiGu
#Biogen is facing #biosimilar competition to its big-selling #multiplesclerosis therapy Tysabri in the US for the first time, as #Sandoz enters the market.
pharmaphorum.com/news/sandoz-...
Meanwhile, #Accenture Labs, biotechnology firm #Biogen and quantum computing company #1QBit are collaborating on research related to #drugdiscovery. Quantum computers can compare molecules that are much larger than the ones classical computers can compute, Accenture said on its website.
www.vanquabio.com/vanqua-bio-t...
Looking for this #C5aR1 data. If you attended, could you please share ?
#VanquaBio #InflaRx $IFRX #Biogen $BIIB
Neuromuscular Disease Therapeutics Market's Surge to $45.62 Billion by 2033 Fueled by Innovative Treatments #United_States #Austin #Biogen #Neuromuscular #gene_therapies
Pharmalot.. Pharmalittle.. Good Morning: We’re reading about Novo Nordisk layoffs, an Amgen discount program & much more news.. statnews.com/pharmalot/20... #pharma #Medicare #obesity #weight #patents #layoffs #medicine #Amgen #Gilead #AstraZeneca #NovoNordisk #Biogen #Roche
Eisai and Biogen Unveil New Approach to Early Alzheimer's Treatment Via LEQEMBI® IQLIK™ Injection #United_States #Cambridge #Eisai #Biogen #LEQEMBI®
#Biogen has reached a deal to buy #AlcyoneTherapeutics, a privately held company that has developed a system for delivering antisense oligonucleotides (#ASOs) directly into the #centralnervoussystem.
